Radiopharm Theranostics: Could this be the technology that finally kicks cancer to the kerb? -

Listen to ASX-listed Radiopharm Theranostics Executive Chairman and biotech entrepreneur Paul Hopper talk to Matt Birney on the Bulls N’ Bears Report about Radiopharm’s brand new “radiopharmaceutical” product that is being developed to seek, illuminate and destroy cancerous cells without impacting the healthy ones.

Radiopharm Theranostics: Could this be the technology that finally kicks cancer to the kerb? -
Listen to ASX-listed Radiopharm Theranostics Executive Chairman and biotech entrepreneur Paul Hopper talk to Matt Birney on the Bulls N&rsquo; Bears Report about Radiopharm&rsquo;s brand new &ldquo;radiopharmaceutical&rdquo; product that is being developed to seek, illuminate and destroy cancerous cells without impacting the healthy ones.

Matt Birney and Bulls N' Bears sit at the epicentre of the small cap ASX-listed company space in Perth and Western Australia. Bulls N’ Bears covers public company news, views and CEO interviews across a number of main stream media platforms in WA. Its financial markets followers, who come from all four corners of the globe, are looking to zero in on Western Australia’s unique international status as the most prolific developer of small capped publicly listed companies in the world.

Matt Birney and Bulls N' Bears sit at the epicentre of the small cap ASX-listed company space in Perth and Western Australia. Bulls N&rsquo; Bears covers public company news, views and CEO interviews across a number of main stream media platforms in WA. Its financial markets followers, who come from all four corners of the globe, are looking to zero in on Western Australia&rsquo;s unique international status as the most prolific developer of small capped publicly listed companies in the world.

Advertisement